GlassScriptPhysician profile
Danny Penick
NPI 1033153614
$621.45
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $10.98 · 2021: $15.67 · 2022: $48.48.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $188.28 | 2019 | |
| Heartflow, INC. | $159.11 | 2019-2022 | |
| Abiomed | $90.39 | 2019 | |
| Daiichi Sankyo INC. | $56.33 | 2019 | |
| Boston Scientific Corporation | $29.15 | 2022 | |
| Pfizer INC. | $28.56 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.22 | 2019 | |
| Amgen INC. | $16.51 | 2019 | |
| Elutia, INC. | $15.67 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $11.23 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Penick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.